Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$577K Buy
2,291
+82
+4% +$17.6K 0.13% 113
2026
Q1
$480K Buy
2,209
+141
+7% +$31.3K 0.14% 115
2025
Q4
$473K Sell
2,068
-411
-17% -$93.6K 0.13% 115
2025
Q3
$561K Sell
2,479
-51
-2% -$10.4K 0.16% 107
2025
Q2
$480K Buy
2,530
+77
+3% +$14.3K 0.15% 116
2025
Q1
$514K Sell
2,453
-153
-6% -$29.7K 0.18% 105
2024
Q4
$457K Buy
2,606
+254
+11% +$46.7K 0.16% 112
2024
Q3
$464K Buy
2,352
+142
+6% +$26.5K 0.17% 105
2024
Q2
$379K Buy
2,210
+433
+24% +$71.7K 0.15% 110
2024
Q1
$324K Buy
+1,777
New +$306K 0.13% 111

Other funds holding ABBV

Umpqua Bank's ABBV Position: Q2 2026 in Review

Umpqua Bank increased its AbbVie (ABBV) stake by 3.7% in Q2 2026, buying an estimated $17.6K and bringing the position to 2,291 shares worth $577K. The position accounts for 0.13% of the portfolio, ranked #113.

Umpqua Bank first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,153 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Umpqua Bank held 2,291 shares of AbbVie worth $577K as of Q2 2026.
  • Umpqua Bank bought 82 AbbVie shares in Q2 2026, an estimated $17.6K.
  • AbbVie made up 0.13% of Umpqua Bank's portfolio in Q2 2026, its #113 holding.
  • Umpqua Bank first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,153 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Umpqua Bank's 13F filing for Q2 2026, filed 24 Jul 2026.